Ibnsina Pharma (EGX:ISPH)

Ibnsina Pharma Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Ibnsina Pharma stock has a consensus rating of "Strong Buy" and an average price target of E£17.26. The average 1-year stock price forecast is 37.97% higher than the current stock price, while the lowest is E£14.50 (+15.91%) and the highest is E£21.00 (+67.87%).

Price Target: E£17.26 (+37.97%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	E£14.50	E£17.26	E£16.77	E£21.00
Change	+15.91%	+37.97%	+34.05%	+67.87%

Analyst Ratings

The average analyst rating for Ibnsina Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Nov '25	Jan '26	Feb '26	Mar '26	May '26
Strong Buy	3	2	2	0	1	2
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	3	3	1	2	3

Financial Forecast

Revenue This Year

90.63B

Increased by 18.31%

from 76.60B

Revenue Next Year

102.57B

Increased by 13.18%

from 90.63B

EPS This Year

0.90

from -

EPS Next Year

1.40

Increased by 55.56%

from 0.90

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	21.73B	22.26B	33.95B	55.84B	76.60B	90.63B
Revenue Growth	16.35%	2.45%	52.48%	64.49%	37.17%	18.31%
Gross Profit	1.63B	1.62B	2.52B	4.40B	6.45B	7.39B
Gross Margin	7.50%	7.26%	7.41%	7.87%	8.42%	8.15%
Operating Income	667.35M	482.22M	1.15B	2.26B	3.54B	3.94B
Net Income	314.73M	172.58M	213.66M	614.56M	951.98M	1.35B
EPS	-	-	-	-	-	0.90
Forward PE	9.83	3.90	10.44	11.62	8.77	13.90
Dividend / Share	0.09	-	-	0.16	-	0.36
Free Cash Flow	-617.13M	-1.50B	-2.72B	-7.04B	-6.38B	1.32B
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EGP.

Revenue Forecast

Revenue	2026	2027	2028
High	91.7B
Avg	90.6B
Low	89.6B

Revenue Growth

Revenue Growth	2026	2027	2028
High	19.7%
Avg	18.3%
Low	17.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.90
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	55.6%
Low	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.